Dear All,
I hope you all enjoyed your weekend! Just a gentle reminder about the LHEG meeting this Thursday hosted by LSHTM. Please see all the details below. Note the slightly later start time at 5.30pm.
We hope you can make it!
All the best
Victoria
-----Original Message-----
From: London Health Economics Group <[log in to unmask]> On Behalf Of Victoria Serra-Sastre
Sent: 29 March 2023 14:37
To: [log in to unmask]
Subject: LHEG meeting 27 April 5.30-7.30pm at LSHTM
CAUTION: This email originated from outside of the organisation. Do not click links or open attachments unless you recognise the sender and believe the content to be safe.
Dear All,
We hope you are all well in the run up to the Easter break. We just wanted to share with you the date of the next LHEG meeting, which will be on the 27th April 5.30-7.30pm and kindly hosted by LSHTM. Our two speakers for this meeting will be Sean Sullivan and Jannis Stöckel. Many thanks to them and to the host LSHTM, for their help in organising the event. Please see details of the presentations below:
- Sean D. Sullivan (University of Washington and Department of Health Policy, LSE)
Title: Medicare Drug Price Negotiation in the US: Implications and Unanswered Questions
Abstract: The U.S. is a relatively free-pricing market for pharmaceutical manufacturers to set list prices at product launch. Few drug price controls exist, and federal price negotiation as a policy has historically been politically untenable. After decades of debate on whether the federal government, specifically the Medicare program, should more actively manage drug prices, the U.S. Congress passed legislation authorizing Medicare to directly negotiate prices with manufacturers. The purpose of this presentation is to describe elements of the price negotiation provisions and then comment on the potential impacts on payers, innovation, and the pharmaceutical industry. While impacting only a few drugs each year in the beginning, price negotiation in the Medicare program will have secondary and longer-term effects in the US market and beyond. What is clear is that the Medicare market in the US for drugs will no longer be a free-pricing environment for the industry.
- Jannis Stöckel (Department of Health Policy, LSE)
Title: Staying sick but feeling better? – The Impact of Health Shocks on Health Perceptions and Behaviors
Abstract: We study health events as sources of information shaping health perceptions and behaviours within families. By combining individual-level administrative data and survey data from the Netherlands we estimate the short-, medium- and long-term causal effect of suffering from a heart attack or stroke on the health perceptions and behaviours of patients and spouses of patients. Our identification strategy exploits the exogenous timing of these health shocks in a treated vs not-yet-treated event-study design. Experiencing a heart attack or stroke leads to a strong downward adjustment in perceived health remaining persistent for multiple years after the health event. This adjustment goes beyond the realized changes in latent health status, measured using functional limitations, indicating severe health events to influence perceived health via expected future health changes and a re-evaluation of latent risk factors. In line with this, we observe strong and persistent decreases in smoking prevalence and alcohol consumption and a persistent uptake of preventive medication use, but no behavioural responses in the exercising frequency or being overweight. In line with the effects on perceived health and health behaviours, we also observe changes in health insurance coverage via the voluntary deductible individuals choose to decrease their financial exposure in case of future health events. Unlike the strong effects across domains found among patients themselves, we find only limited evidence for spillover effects on spouses of patients. Our results underline the importance of experienced health events as drivers of health perceptions and behaviours but also suggest that previously reported intra-family spillovers following severe health shocks might be constrained depending on the specific healthcare system’s context in which they are studied.
The meeting will be in room Jerry Morris A&B, Tavistock Building, LSHTM. To find the venue, please use the address below (searching for LSHTM on apps/search engines will take you to the building in Keppel Street):
Tavistock building
Jerry Morris A & B
Ground Floor
London School of Hygiene & Tropical Medicine
15-17 Tavistock Place
Kings Cross
London WC1H 9SH
United Kingdom
If you wish to attend please register here: https://cityunilondon.eu.qualtrics.com/jfe/form/SV_eUKpIPGPG0qYy8e
There will be informal drinks after the meeting, so please join us for the presentations and the social afterwards!
All the best,
Victoria
Department of Economics |City, University of London
CHEC: https://researchcentres.city.ac.uk/health-economics#unit=people
########################################################################
To unsubscribe from the LHEG list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=LHEG&A=1
This message was issued to members of www.jiscmail.ac.uk/LHEG, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
|